Company research

IMMUNOVANT INC

IMVT

Current Tracked Holders
1
One-Year Insider Activity
Purchases 1 $350.0M
Sales 56 $15.7M

Price history

Price history loads when this section approaches view.

Quarter-End Change Analysis

No published quarterly analysis yet

Reviewed research will appear here when it is published.

Current reported holders

Portfolio ManagerRecent activitySharesValuePortfolio
David EinhornDME Capital Management, LP
IMVTNew
93,520
$2,323,000
0.07%

Long-term company research

Fundamental analysis

Research pending

Fundamental research pending

Reviewed company research will appear here when available.

Financial data loads when this section approaches view.

Insider activity

One-year insider activity

Open-market purchases and sales only.

Checked 2026-08-11
DateInsiderTypeSharesPriceValueSource
2026-07-24Pande AtulDirectorSale1,500$40$59,700SEC ↗
2026-07-23Stout Jay SChief Technology OfficerSale2,857$39$110,537SEC ↗
2026-07-23Girao TiagoChief Financial OfficerSale6,798$39$263,015SEC ↗
2026-07-08Gloria MelanieChief Operating OfficerSale1,930$40$76,293SEC ↗
2026-07-08Gloria MelanieChief Operating OfficerSale106$40$4,239SEC ↗
2026-07-08Van Tuyl ChristopherChief Legal OfficerSale1,143$40$45,183SEC ↗
2026-07-08Van Tuyl ChristopherChief Legal OfficerSale63$40$2,519SEC ↗
2026-07-08Stout Jay SChief Technology OfficerSale1,906$40$75,344SEC ↗
2026-07-08Stout Jay SChief Technology OfficerSale105$40$4,199SEC ↗
2026-07-08Stout Jay SChief Technology OfficerSale1,399$40$55,302SEC ↗
2026-07-08Stout Jay SChief Technology OfficerSale77$40$3,079SEC ↗
2026-07-02Venker EricDirector, Chief Executive OfficerSale3,092$38$118,980SEC ↗
2026-06-26Gloria MelanieChief Operating OfficerSale14,748$38$563,079SEC ↗
2026-06-26Gloria MelanieChief Operating OfficerSale2,966$39$115,526SEC ↗
2026-06-26Stout Jay SChief Technology OfficerSale33,277$38$1.3MSEC ↗
2026-06-26Stout Jay SChief Technology OfficerSale6,723$39$261,794SEC ↗
2026-06-26Van Tuyl ChristopherChief Legal OfficerSale14,982$38$572,163SEC ↗
2026-06-26Van Tuyl ChristopherChief Legal OfficerSale2,842$39$110,724SEC ↗
2026-06-26Girao TiagoChief Financial OfficerSale10,000$38$384,600SEC ↗
2026-06-26Pande AtulDirectorSale1,500$38$57,015SEC ↗
Older transactions
DateInsiderTypeSharesPriceValueSource
2026-06-18Van Tuyl ChristopherChief Legal OfficerSale2,634$35$93,217SEC ↗
2026-06-15Pande AtulDirectorSale1,500$34$51,030SEC ↗
2026-05-28Fromkin Andrew J.DirectorSale11,483$33$374,805SEC ↗
2026-05-28Fromkin Andrew J.DirectorSale210,468$34$7.1MSEC ↗
2026-05-20Gloria MelanieChief Operating OfficerSale249$30$7,572SEC ↗
2026-05-20Gloria MelanieChief Operating OfficerSale1,168$32$37,551SEC ↗
2026-05-20Gloria MelanieChief Operating OfficerSale1,698$33$55,949SEC ↗
2026-05-20Pande AtulDirectorSale6,000$32$192,000SEC ↗
2026-05-01Susman Robert GrahamDirectorSale2,502$27$67,979SEC ↗
2026-04-23Girao TiagoChief Financial OfficerSale25,760$30$763,011SEC ↗
2026-04-23Stout Jay SChief Technology OfficerSale2,754$30$81,573SEC ↗
2026-04-08Gloria MelanieChief Operating OfficerSale8,722$25$216,567SEC ↗
2026-04-08Van Tuyl ChristopherChief Legal OfficerSale5,165$25$128,247SEC ↗
2026-04-08Stout Jay SChief Technology OfficerSale8,614$25$213,886SEC ↗
2026-04-08Stout Jay SChief Technology OfficerSale1,518$25$37,692SEC ↗
2026-04-02Venker EricDirector, Chief Executive OfficerSale12,820$24$308,193SEC ↗
2026-04-02Venker EricDirector, Chief Executive OfficerSale1,409$25$34,661SEC ↗
2026-03-18Van Tuyl ChristopherChief Legal OfficerSale2,877$25$71,839SEC ↗
2026-02-25Gloria MelanieChief Operating OfficerSale1,437$27$38,770SEC ↗
2026-02-25Gloria MelanieChief Operating OfficerSale859$28$24,189SEC ↗
2026-02-25Gloria MelanieChief Operating OfficerSale942$29$27,224SEC ↗
2026-01-21Stout Jay SChief Technology OfficerSale1,977$26$51,461SEC ↗
2026-01-07Stout Jay SChief Technology OfficerSale1,148$27$30,433SEC ↗
2026-01-07Stout Jay SChief Technology OfficerSale55$27$1,481SEC ↗
2025-12-18Van Tuyl ChristopherChief Legal OfficerSale8,529$27$228,407SEC ↗
2025-12-18Van Tuyl ChristopherChief Legal OfficerSale2,284$27$62,536SEC ↗
2025-12-12Roivant Sciences Ltd.Purchase16,666,666$21$350.0MSEC ↗
2025-12-01Fromkin Andrew J.DirectorSale19,351$23$447,782SEC ↗
2025-12-01Fromkin Andrew J.DirectorSale2,898$24$69,407SEC ↗
2025-12-01Hughes Douglas J.DirectorSale13,091$23$302,926SEC ↗
2025-12-01Hughes Douglas J.DirectorSale1,909$24$45,740SEC ↗
2025-11-20Gloria MelanieChief Operating OfficerSale10,251$24$241,309SEC ↗
2025-11-20Gloria MelanieChief Operating OfficerSale2,375$24$56,929SEC ↗
2025-10-22Geffner MichaelChief Medical OfficerSale2,595$19$49,383SEC ↗
2025-10-22Stout Jay SChief Technology OfficerSale2,520$19$47,956SEC ↗
2025-10-08Geffner MichaelChief Medical OfficerSale1,272$16$20,734SEC ↗
2025-10-08Stout Jay SChief Technology OfficerSale1,585$16$25,836SEC ↗